Home >> Services >> All Other
 Interventional Cardiology Devices Market – Global industry analysis and forecast (2019-2026)
Posted on : Monday, 24 February, 2020  09:19
Location : Omkar Heights,, Sinhagad Road,, Manik Baug, Vadgaon Bk,, Pune, M, Munshiganj, Dhaka
Phone Number# : 09607365656
URL : Website Link

Interventional Cardiology Devices Market is expected to reach US$ XX Bn by 2026 at a CAGR of 7.5 % during the forecast period.

Interventional Cardiology Devices Market

Interventional cardiology is a branch of cardiology that offers precisely with the catheter-based treatment of structural coronary heart diseases. The principal advantages of using the interventional cardiology is the avoidance of the scars, pain and long post-operative healing.

An increasing prevalence of cardiovascular diseases, an increase in patient awareness, unhealthy lifestyle habits such as high alcohol consumption, lack of physical exercise, smoking would create commercial market opportunities. Moreover, numerous instances related to product failure and a product recall are expected to restrain the demand for these techniques within the near future.

Interventional cardiology devices market is segmented by type and region. Among type, angioplasty balloon and angioplasty stent accounted for the XX% share in 2018, an angioplasty balloon is projected to develop at the XX% growth rate in the coming future due to rising demand for minimally invasive procedures for coronary artery diseases.

Among regions, the North America is expected to grow at the XX% CAGR during the forecast period due to the presence of favorable government initiatives, increasing new product development, increasing incidence of cardiovascular diseases, and surge in the demand for minimally invasive devices. The APAC is expected to grow at the XX% CAGR during the forecast period due to rising healthcare expenditure, the presence of large untapped opportunities, cardiovascular disease incidence rate, and disposable income levels.

Among the key players, Abbott labs have visible sturdy sales boom within the recent past, primarily reflecting the effect of acquisitions it made during the last couple of years. Abbott is seeing sturdy development in its medical devices and generic pharmaceuticals business. The company expects this trend to continue in the near future. In 2018, Abbott’s Diagnostics business to see a sharp rise in revenues to the north of $7 billion. Primarily due to the influence of the Alere acquisition.

For More Information Visit @: https://www.maximizemarketresearch.com/market-report/interventional-cardiology-devices-market/13745/

  In this Ad : Offering a service
  Posted By: An Individual
  It is ok to contact this poster with commercial interests.

Home Browse Cities Sitemap Privacy Policy Disclaimer Contact Us

Copyright © 2014 Unolist LLC. All rights reserved.